DNM1L and breast carcinoma: Specifically, amplifications of OPA1, MFN1, and DNM1L (encoding Drp1) were found in more than 5% of high-grade serous ovarian cancers (HGSOC), breast carcinomas, and lung adenocarcinomas [25].